Active-ingredient Dossier
Glimepiride
Active-ingredient Dossier for Glimepiride (meglitinide analog). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: GLIMEPIRIDE B&B
- Brand: GLIMEPIRIDE SANDOZ
- Brand: GLIMEPIRIDE-WGR
- Brand: GLIMIRIDE
- Brand: GLIRIDE
- Brand: NECARAL
- Therapeutic area: Endocrinology
What is
Glimepiride Glimepiride is a meglitinide analog used in therapeutics.
Australian brands containing
Glimepiride — GLIMEPIRIDE B&B — GLIMEPIRIDE SANDOZ — ARX-GLIMEPIRIDE — GLIMEPIRIDE-WGR — GLIMIRIDE — GLIRIDE — NECARAL
Therapeutic areas
Glimepiride is registered in endocrinology, with 11 brands containing the ingredient on the ARTG.
Sponsor landscape
Five sponsors market glimepiride in Australia: Accord Healthcare, Micro Labs, Arrotex Pharmaceuticals, Sandoz, and Medsurge Pharma.
PBS and regulatory activity
Two brands containing glimepiride have PBS-listed items, with the latest PBS schedule date of 1 May 2026.